financetom
Business
financetom
/
Business
/
Paramount jumps as steady streaming growth eclipses TV unit writedown
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paramount jumps as steady streaming growth eclipses TV unit writedown
Aug 9, 2024 6:08 AM

(Reuters) - Paramount Global's ( PARAA ) shares jumped 6% premarket on Friday as investors cheered strong growth at the media group's streaming business, even as the company joined rival Warner Bros Discovery in writing down the value of its TV assets.

Paramount late on Thursday comfortably beat Wall Street targets for earnings, propelled by its streaming unit, which houses Paramount+ and PlutoTV services, posting its first quarterly profit in three years. The company also said it would cut 15% of its U.S. workforce, part of its cost-cutting plans ahead of its merger with Skydance Media.

The streaming profit eclipsed Paramount's writedown of the value of its cable networks by about $6 billion, a move that highlights the erosion of traditional TV businesses as viewership dwindles and revenues decline in the streaming era.

"Results in the rest of Paramount's business were unsurprisingly weak, but at Paramount's current market value, it shouldn't take much good news to generate enthusiasm," Morningstar analyst Matthew Dolgin said.

Revenue at Paramount+ surged 46% in the second quarter, aided by year-on-year growth in subscribers as well as higher prices. Paramount's television unit, meanwhile, saw a 17% decline in revenue.

Earlier this week, Warner Bros Discovery announced a $9 billion charge on its TV assets.

Paramount, like other media companies, has been beefing up its streaming business with plans to grab a wider audience - the company earlier this year signed a deal with U.S. cable giant Charter Communications to give Charter's Spectrum TV customers access to Paramount+ ad-supported service.

"While the viewership of linear networks has declined significantly, and Paramount+ is not currently in the same league as the biggest and most popular streaming platforms, we still see advantages to the menu of distribution that Paramount offers," Dolgin added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Digital publisher Arena Group's Q3 net income misses estimates
Digital publisher Arena Group's Q3 net income misses estimates
Nov 13, 2025
Overview * Arena Group Q3 2025 revenue declined, missing analyst expectations * Net income for Q3 2025 rose 73% yr/yr but missed analyst estimates * Adjusted EBITDA for Q3 2025 increased by 6.3% over Q3 2024 Outlook * Company emphasizes growth in data, AI, and e-commerce as future drivers * Arena Group ( AREN ) highlights audience volatility as a...
SeaStar Medical Q3 net loss narrows
SeaStar Medical Q3 net loss narrows
Nov 13, 2025
Overview * SeaStar Medical ( ICU ) Q3 net loss narrows to $3.5 mln from $4.5 mln year-over-year * Company raised $12.4 mln to strengthen balance sheet and fund future operations * SeaStar Medical ( ICU ) expands QUELIMMUNE therapy to three new top-rated children's hospitals Outlook * Company raised $12.4 mln to support future operations * SeaStar Medical (...
US corporate bankruptcies set to hit 15-year high amid credit jitters, S&P data shows
US corporate bankruptcies set to hit 15-year high amid credit jitters, S&P data shows
Nov 13, 2025
(Reuters) -Large U.S. corporate bankruptcies are on pace to hit their highest level in 15 years, S&P Global data showed on Thursday, underscoring mounting stress across corporate America at a sensitive time for public market investors. Total bankruptcy filings reached 655 this year through October, compared with 687 for all of 2024. October alone accounted for 68 filings, following 76...
Biopharmaceutical company Precigen Q3 net loss widens 
Biopharmaceutical company Precigen Q3 net loss widens 
Nov 13, 2025
Overview * Precigen ( PGEN ) Q3 net loss widens significantly due to non-cash items like warrant liabilities * PAPZIMEOS receives FDA approval, launches as first treatment for adults with RRP * Company advances PAPZIMEOS commercialization with over 90% target institutions engaged * Cash, cash equivalents, and investments totaled $123.6 million as of September 30, 2025 Outlook * Company expects...
Copyright 2023-2026 - www.financetom.com All Rights Reserved